Who is vulnerable to meningitis? Anyone can contract the disease but it is more common in people with weakened immune systems ...

Advancement to Stage 2 of Infant Study Supported by Review of Stage 1 Safety and Tolerability Data ---- Company Expects to Announce VAX-31 Infant Study Topline Safety, Tolerabi ...

antibiotic resistance, and meningitis," said Vaxcyte's chief operating officer, Jim Wassil. VAX-31 has the potential to be "a best-in-class pneumococcal vaccine capable of raising the bar for ...

meningitis, sepsis or other serious diseases. If the bacteria spread to the sinuses or the middle ear, this can lead to sinusitis or otitis media, a painful type of ear infection. “Antibiotic ...

Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ETCompany ParticipantsAndrew Guggenhime - President and ...

plus another seven that are linked to invasive pneumococcal disease (IPD) and have been associated with high fatality rates, antibiotic resistance and meningitis. All told, the 20 serotypes ...

Completed Successful VAX-31 Phase 2 Adult Program; Company Remains on Track to Initiate VAX-31 Adult Phase 3 Pivotal, Non-Inferiority Study by ...

Bacterial meningitis is a serious infection of the lining of the brain. Sickle cell disease also raises the risk of bacteremia, a bacterial infection of the blood. Without antibiotics ... who have not ...

Antimicrobial resistance and serotypes in Streptococcus pneumoniae have been evolving with the widespread use of antibiotics and the introduction of pneumococcal conjugate vaccines (PCV).